Search results
Two shots in one? Moderna's COVID-19 and flu vaccine reports favorable results
USA Today· 5 days agoModerna said Monday that its combination vaccine against flu and COVID-19 drew a greater immune...
KP.3 is the dominant COVID-19 variant in the US: Latest on test positivity, deaths, symptoms
USA TODAY via Yahoo News· 2 days agoThe updated vaccines are set to be released in the fall, ahead of expected winter upticks in COVID-19 cases. Contributing ...
FDA asks COVID vaccine makers to target KP.2 strain, if feasible, for next shot
Reuters via Yahoo News· 14 hours agoThe Food and Drug Administration's change in recommendation, in an update dated Thursday, comes even...
Moderna’s New Flu-COVID Combi mRNA Vaccine Outperforms Separate Shots In Trials
IFLScience· 4 days agoModerna became a household name thanks to the success of its mRNA vaccine against COVID-19. Along...
FDA advises Covid vaccine makers to target KP.2 for fall shots
NBC News via Yahoo News· 1 day agoThe FDA advised drugmakers to update Covid vaccines to target the KP.2 strain, a descendant of the...
Doctor: Diminished COVID-19 could present potential 'summer wave of sickness'
News 12 New Jersey· 6 days agoThe Food and Drug Administration recently voted to ask drug manufactures to update the COVID-19 vaccine formula to ...
COVID-flu combination vaccine shows positive results in late-stage trial, Moderna says
WPTZ Burlington· 5 days agoThere could be a combined COVID-19 and flu shot in our future, although it won’t be ready for this...
New COVID-19 strain KP.3 circulating in US. What is the situation in Riverside County?
The Desert Sun· 6 hours agoA new COVID-19 variant called KP.3 is on the rise in the United States and has been detected in...
Covid-flu combination vaccine shows positive results in late-stage trial, Moderna says
Crossroads Today· 5 days agoOn Monday, vaccine maker Moderna announced positive late-stage trial results for its Covid-flu...
FDA to vaccinemakers: Updated COVID shots should target KP.2 variant
Becker’s Hospital Review· 1 day agoThe FDA is now advising manufacturers to develop the 2024-2025 COVID-19 vaccines using the KP.2 strain for the formula, the agency announced ...